Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Merck Secures FDA Approval for Winrevair, Revolutionizing Treatment for Pulmonary Arterial…
Indaptus Therapeutics (NASDAQ:INDP): Pioneering the Future of Cancer and Viral Infection…
Pharmaceutical Giants Navigate Market Tides: A Glimpse into the Future of…
Vocodia Holdings (VHAI) to Transform Auto Dealership Experience with Groundbreaking AI…
Black Diamond Therapeutics Inc (NASDAQ:BDTX) Surges on Market Optimism
Finance
Biotech Stocks Take Centerstage as Markets Turn Red (COEP,AMLX, BMRN, EXEL,…
S&P 500 could move higher as per technical analysis (ARM, S&P)
Health Department Urges DEA to Reevaluate Marijuana Restrictions (TLRY,ACB,CURLF,CGC)
Stocks in Focus as markets take a break from rallying (QQQ,NVO,ANET)
BYND Cannasoft (BCAN): A Small-Cap Enterprise with Exceptional Growth Prospects in…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
Atossa Therapeutics Inc (NASDAQ:ATOS)
Tag: Atossa Therapeutics Inc (NASDAQ:ATOS)
Atossa Therapeutics Inc (NASDAQ:ATOS) Reports Positive Interim Results From Phase 2...
Kate Hudson
-
April 12, 2021
0
Atossa Therapeutics Pleased After FDA Gives It A “Safe To Proceed”...
Kate Hudson
-
March 18, 2021
0
Atossa Therapeutics Inc (NASDAQ:ATOS) Reports Tolerability And Safety Of AT-301 In...
Matt Wade
-
March 10, 2021
0
Atossa Therapeutics Inc (NASDAQ:ATOS) Reports Positive Outcome In A Two-Year Treatment...
Kate Hudson
-
February 26, 2021
0
The Clinical Study of AT-301 Nasal Spray in the First Group...
Kate Hudson
-
September 15, 2020
0
1
2
3
Page 2 of 3
Recent Post
Merck Secures FDA Approval for Winrevair, Revolutionizing Treatment for Pulmonary Arterial...
Kate Hudson
-
March 26, 2024
0
In a landmark development, the U.S. Food and Drug Administration recently endorsed a groundbreaking therapy by Merck, setting a new course for...
Indaptus Therapeutics (NASDAQ:INDP): Pioneering the Future of Cancer and Viral Infection...
March 25, 2024
Pharmaceutical Giants Navigate Market Tides: A Glimpse into the Future of...
March 25, 2024
Vocodia Holdings (VHAI) to Transform Auto Dealership Experience with Groundbreaking AI...
March 25, 2024
Black Diamond Therapeutics Inc (NASDAQ:BDTX) Surges on Market Optimism
March 22, 2024